Target intelligence / Profile preview

Poisons

Molecular classification
Other
01

Overview

"Poisons" is a broad term describing any chemical or biological substance that causes harmful physiological effects, injury, or death to a living organism upon exposure [7, 13]. In the field of pharmacology and drug discovery, "Poisons" is not recognized as a specific therapeutic target molecule, such as a receptor or enzyme, but is instead used as a functional classification for substances that disrupt essential biological processes [6, 19]. A prominent clinical example involves topoisomerase poisons, which are a class of chemotherapy agents (e.g., etoposide, topotecan) that convert their target enzymes into cellular toxins by stabilizing DNA-enzyme cleavage complexes, leading to lethal DNA double-strand breaks [10]. Additionally, numerous natural poisons derived from plants and animals have been successfully repurposed into therapeutic agents, such as botulinum toxin (Botox) for muscle disorders and captopril, which was developed based on snake venom components [1, 9, 16]. Because the term refers to an immense variety of substances with distinct molecular mechanisms—including irreversible enzyme inhibition, DNA adduction, and ion channel blockade—it is considered an overly generic and non-specific descriptor rather than a discrete biological target [5, 8].

Other names
ToxinsToxicantsVenomsBiotoxinsPhytotoxinsZootoxinsTopoisomerase poisonsMitotic poisons
02

Mechanism of action

Poisons exert their effects through diverse and often irreversible mechanisms, most notably by stabilizing DNA-enzyme cleavage complexes (topoisomerase poisons), inhibiting neurotransmitter release at the neuromuscular junction, blocking membrane ion channels, or irreversibly inhibiting critical metabolic enzymes [10, 16, 17, 19].

03

Biological functions

Cell deathApoptosisDefense mechanismEnzyme inhibitionIon channel blockadeSignal transduction interference
04

Disease associations

PoisoningCancerInfectionCardiovascular diseaseNeurotoxicityEnvenomation
05

Safety considerations

Systemic toxicityNarrow therapeutic indexLethalityOff-target reactivityAccidental exposure
06

Interacting drugs

Etoposide

7 more in the full profile.

07

Biomarkers

Serum poison/toxin levelsLactate dehydrogenase (LDH)Alanine aminotransferase (ALT)DNA topoisomerase I (TOP1) expressionDNA topoisomerase II (TOP2) expression

Beyond the preview

Go deeper on Poisons.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poisons.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call